InvestorsHub Logo
icon url

abew4me

10/24/20 11:53 AM

#278360 RE: Gernee20 #278283

No. It will vary based on their scheduling and staffing to review the data. And once the company has the guidance back from the FDA, it's up to them as to when they will proceed.